GXO heads into the week with a notable divergence: options traders have turned sharply more defensive, while short sellers have been steadily rebuilding positions for the past month.
The clearest signal this week comes from the options market. The put/call ratio has jumped to 2.16 — nearly double its 20-day average of 1.25, and 1.5 standard deviations above the mean. That's a meaningful spike, and the timing matters: the ratio was hugging 0.98 through most of June before shooting higher on June 22 and holding there. Demand for downside protection has risen sharply and quickly. The 52-week high for the PCR is 3.34, hit back in May, which offers some context — this isn't the most defensive the market has been on GXO, but it's a notable step in that direction.
Short interest tells a quieter but equally persistent story. At 5.3% of free float, GXO is meaningfully shorted — up roughly 20% over the past month from a base around 4.4% in mid-May. The week-on-week change is a modest +2%, and Monday's daily reading dipped slightly, so the pace of accumulation may be slowing. Crucially, the borrow market puts no strain on that position: availability is at 359%, meaning there are more than three shares available to lend for every one already borrowed. Cost to borrow has dropped around 12% on the week to a negligible 0.38%. Adding shorts here is cheap and unconstrained — the short-score reading of 50.7 reflects a mid-table level of stress, with the short-score percentile rank at just 17. None of this looks squeezable.
The Street is notably more constructive than current positioning implies. The analyst consensus is a buy, and all four covering analysts are either outperform or neutral — not a single sell. The mean price target of $70.67 implies roughly 45% upside from Tuesday's close of $48.83. The most recent action worth flagging came from Barclays on May 27, when analyst Brandon Oglenski upgraded GXO to Overweight and raised the target to $65 from $58. Before that, Wells Fargo trimmed its target modestly in early May while keeping its Overweight rating — a familiar pattern of constructive but measured Street sentiment. The analyst recommendation differential scores in the 100th percentile, the highest possible reading. On valuation, GXO trades at 14.9x trailing earnings and 10.6x EV/EBITDA — both multiples have edged down over the past week, suggesting the recent pullback has made the setup incrementally cheaper.
The peer group offered little comfort this week. FDX fell 6.4% on the week — the worst performer in the group — while UPS dropped 2.8%. GXO's own 2.3% weekly decline lands roughly in the middle of the pack, which at least suggests the sector-wide pressure is not specific to GXO. The ORTEX stock score recently pulled back from a June peak near 73, with momentum the driver of the retreat while value (score 63.9) and growth remain the strongest pillars.
The next earnings date is August 4. The last three prints all produced positive next-day moves of between 2.6% and 4.1%, with the Q1 2026 result adding 7.9% in a single session. Whether the current defensive options skew and rebuilt short interest reflect genuine fundamental concern or simply sector-wide caution is the question worth tracking as that date approaches.
See the live data behind this article on ORTEX.
Open GXO on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
